Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.32 |
| ▸ | CDK9 | P50750 | 1/20 | 0.32 |
| ▸ | ARG1 | P05089 | 1/20 | 0.31 |
| ▸ | ARG2 | P78540 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24033707 | 1.00 | HTR6 (0.44) | HTR6CCNT1CDK9ARG1ARG2 | |
| Hydrochloric Acid SCHEMBL29134756 | 0.98 | HTR6 (0.42) | HTR6CCNT1CDK9ARG1ARG2 | |
| Hydrochloric Acid SCHEMBL34473706 | 0.98 | HTR6 (0.42) | HTR6CCNT1CDK9ARG1ARG2 | |
| SCHEMBL31209270 | 0.90 | HTR6 (0.48) | HTR6 | |
| SCHEMBL24672972 | 0.88 | HTR6 (0.50) | HTR6ARG1ARG2 | |
| SCHEMBL15363274 | 0.87 | HTR6 (0.52) | HTR6 | |
| SCHEMBL31209586 | 0.87 | HTR6 (0.52) | HTR6 | |
| SCHEMBL2372206 | 0.87 | HPGD (0.34) | — | |
| SCHEMBL2675204 | 0.87 | HPGD (0.34) | — | |
| SCHEMBL30814430 | 0.87 | HTR6 (0.42) | HTR6ARG1ARG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10654856-B2 | Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereof | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2020-05-19 | — | — | US | disclosed |
| US-20190040072-A1 | METHOD FOR PREPARING PYRROLO[3,2-D]PYRIMIDINE COMPOUND, AND INTERMEDIATES THEREOF | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2019-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190040072-A1 | METHOD FOR PREPARING PYRROLO[3,2-D]PYRIMIDINE COMPOUND, AND INTERMEDIATES THEREOF | DPYD, TYMS, TYMP | HTR6 2136/4885CCNT1 196/4885CDK9 50/4885 |
| US-10654856-B2 | Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereof | DPYD, TYMS, TYMP | HTR6 2136/4885CCNT1 196/4885CDK9 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.